General Information of the Compound
Compound ID
CP0036700
Compound Name
6-Chloro-3-methyl-9-(3-methyl-but-2-enyloxy)-2,3,4,5-tetrahydro-1H-benzo[d]azepine
    Show/Hide
Synonyms
SK&F-104078
SK-104078
    Show/Hide
Structure
Formula
C16H22ClNO
Molecular Weight
279.811
Canonical SMILES
CN1CCc2c(Cl)ccc(OCC=C(C)C)c2CC1
    Show/Hide
InChI
InChI=1S/C16H22ClNO/c1-12(2)8-11-19-16-5-4-15(17)13-6-9-18(3)10-7-14(13)16/h4-5,8H,6-7,9-11H2,1-3H3
    Show/Hide
InChIKey
MBYSTKNEMJZSIK-UHFFFAOYSA-N
CAS
110857-22-2
Physicochemical Property
logP
3.7154
Rotatable Bonds
3
Heavy Atom Count
19
Polar Areas
12.47
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
2
Complexity
19

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 122295
SID: 14824432
ChEMBL ID
CHEMBL114166
Clinical Information about the Compound
Drug 1 ( SK&F-104078 )
Drug Name SK&F-104078
Target(s)
Adrenergic receptor alpha-1B (ADRA1B)
Inhibitor
Adrenergic receptor alpha-1A (ADRA1A)
Inhibitor
Adrenergic receptor alpha-1D (ADRA1D)
Inhibitor
Adrenergic receptor alpha-2A (ADRA2A)
Inhibitor
Adrenergic receptor alpha-2B (ADRA2B)
Inhibitor
Adrenergic receptor alpha-2C (ADRA2C)
Inhibitor